Cargando…
培美曲塞维持治疗恶性胸膜间皮瘤患者的疗效和安全性分析
BACKGROUND AND OBJECTIVE: Malignant pleural mesothelioma (MPM) is a highly aggressive disease arising from pleural mesothelial cells. Advanced pleural mesothelioma has a poor prognosis, with a median survival of no more than 15 months. First line standard chemotherapy regimen recommended is Pemetrex...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8796129/ https://www.ncbi.nlm.nih.gov/pubmed/35078279 http://dx.doi.org/10.3779/j.issn.1009-3419.2021.101.48 |